Fernanda P. Silveira

Fernanda P. Silveira

Auto-generated profile, based on publicly available information

Fernanda P. Silveira

University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2013 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
FSF. P. Silveira
F. P. Silveira
SKS. Kusne
S. Kusne
TPthe AST Infectious Diseases Community of Practice
the AST Infectious Diseases Community of Practice
Click on the article title to read more.

29 May 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HTH Keipp Talbot
H Keipp Talbot
EMEmily T Martin
Emily T Martin
MGManjusha Gaglani
Manjusha Gaglani
DMDonald B Middleton
Donald B Middleton
SGShekhar Ghamande
Shekhar Ghamande
AMArnold S Monto
Arnold S Monto
Background: Novel coronavirus disease 2019 (COVID-19) is frequently compared with influenza. The Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) conducts studies on the etiology and characteristics of U.S. hospitalized adults with influenza. It began enrolling patients with COVID-19 hospitalizations in March 2020. Patients with influenza were compared with those with COVID-19 in the first months of the U.S. epidemic. Methods: Adults aged ≥ 18 years admitted to hospitals in 4 sites with acute respiratory illness were tested by real-time reverse transcription polymerase chain reaction for influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19. Demographic and illness characteristics were collected for influenza illnesses during 3 seasons 2016–2019. Similar data were collected on COVID-19 cases admitted before June 19, 2020. Results: Age groups hospitalized with COVID-19 (n = 914) were similar to those admitted with influenza (n = 1937); 80% of patients with influenza and 75% of patients with COVID-19 were aged ≥50 years. Deaths from COVID-19 that occurred in younger patients were less often related to underlying conditions. White non-Hispanic persons were overrepresented in influenza (64%) compared with COVID-19 hospitalizations (37%). Greater severity and complications occurred with COVID-19 including more ICU admissions (AOR = 15.3 [95% CI: 11.6, 20.3]), ventilator use (AOR = 15.6 [95% CI: 10.7, 22.8]), 7 additional days of hospital stay in those discharged alive, and death during hospitalization (AOR = 19.8 [95% CI: 12.0, 32.7]). Conclusions: While COVID-19 can cause a respiratory illness like influenza, it is associated with significantly greater severity of illness, longer hospital stays, and higher in-hospital deaths.

3 January 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
KHKailey Hughes
Kailey Hughes
DMDonald B Middleton
Donald B Middleton
MNMary Patricia Nowalk
Mary Patricia Nowalk
GBGoundappa K. Balasubramani
Goundappa K. Balasubramani
EMEmily T Martin
Emily T Martin
FSFernanda P Silveira
Fernanda P Silveira
Yearly influenza immunization is recommended for immunocompromised (IC) individuals, although immune responses are lower than that for the nonimmunocompromised and the data on vaccine effectiveness (VE) in the IC is scarce. We evaluated VE against influenza-associated hospitalization among IC adults. We analyzed data from adults ≥ 18 years hospitalized with acute respiratory illness (ARI) during the 2017–2018 influenza season at 10 hospitals in the United States. IC adults were identified using prespecified case definitions using electronic medical record data. VE was evaluated with a test-negative case-control design using multivariable logistic regression with polymerase chain reaction–confirmed influenza as the outcome and vaccination status as the exposure, adjusting for age, enrolling site, illness onset date, race, days from onset to specimen collection, self-reported health, and self-reported hospitalizations. Of 3524 adults hospitalized with ARI, 1210 (34.3%) had an immunocompromising condition. IC adults were more likely to be vaccinated than non-IC (69.5% vs 65.2%) and less likely to have influenza (22% vs 27.8%). The mean age did not differ among IC and non-IC (61.4 vs 60.8 years of age). The overall VE against influenza hospitalization, including immunocompetent adults, was 33% (95% confidence interval [CI], 21–44). VE among IC vs non-IC adults was lower at 5% (95% CI, –29% to 31%) vs 41% (95% CI, 27–52) (P < .05 for interaction term). VE in 1 influenza season was very low among IC individuals. Future efforts should include evaluation of VE among the different immunocompromising conditions and whether enhanced vaccines improve the suboptimal effectiveness among the immunocompromised.

1 August 2008 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
FSFernanda P. Silveira
Fernanda P. Silveira
EKEun J. Kwak
Eun J. Kwak
DPDavid L Paterson
David L Paterson
JPJoseph M. Pilewski
Joseph M. Pilewski
KMKenneth R. McCurry
Kenneth R. McCurry
SHShahid Husain
Shahid Husain

29 September 2011 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
ZQZubair A. Qureshi
Zubair A. Qureshi
EKEun J. Kwak
Eun J. Kwak
MNM. Hong Nguyen
M. Hong Nguyen
FSFernanda P. Silveira
Fernanda P. Silveira

1 January 2015 in Journal of Infection
Verified
Journal Article
Closed access
OCOveimar De La Cruz
Oveimar De La Cruz
LMLucio R. Minces
Lucio R. Minces
FSFernanda P. Silveira
Fernanda P. Silveira